Forced osteoarthritis therapy: expanding the scope of the possible

Close metadata

Recommended articles:

Total knee replacement in different age groups. Pirogov Russian Journal of Surgery. 2024;(6):45-50

Adaptation and validity of the critical care pain observation tool: a scoping review. Russian Journal of Pain. 2024;(1):77-83

The intensive care unit pain rating scale: a brief introduction. Russian Journal of Pain. 2024;(1):84-86

Main clinical characteristics of pain in patients with lumbosacral transitional vertebrae. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5):7-13

Features of pain syndrome in vertebrogenic pathology in women. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5):14-21

Pain relief in cervical dystonia following regular long-term botulinum therapy. Russian Journal of Pain. 2024;(2):22-28

By the 50th anniversary of the International Association for the Study of Pain: proclaiming a multidisciplinary approach and joining forces for its implementation. Russian Journal of Pain. 2024;(2):68-75

Dependence of medical rehabilitation effectiveness of patients with somatic diseases and meteopathology on features of weather-forming factors of the Moscow region. Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(3):5-12

Biotechnology in development of new treatments for osteoarthritis. Regenerative Biotechnologies, Preventive, Digital and Predictive Medicine. 2024;(2):57-60

Disease-modifying therapy and adjuvant support in complex therapy of chronic non-specific low back pain. Resolution of the Multidisciplinary Board of Experts. Russian Journal of Pain. 2024;(3):108-116

The article deals the modern concepts of the mechanism of pain in osteoarthritis. It was established that synovial inflammation and immune disorders play an important role in the pathogenesis of pain in osteoarthritis. Hyperproduction of pro-inflammatory cytokines supports inflammation and degradation of cartilaginous tissue in osteoarthritis. The mechanisms of pathogenetic action of chondroitin sulfate are disclosed, and the evidence base of its preclinical and clinical studies in the treatment of osteoarthritis is presented. The data of clinical application of the Mucosat — pharmaceutical substance chondroitin sulfate in the form of a ready-made dosage form for intramuscular injection are presented. The practical advantages of including SYSADOA in complex therapy of osteoarthritis are discussed.

Keywords:

osteoarthritis

pain

proinflammatory cytokines

chondroprotectors

chondroitin sulfate

Mucosat

Authors:

Mezenova T.V.

Russian Academy of Postgraduate Education, Moscow, Russia

List of references:

Cross M, Smith E, Nolte S, Ackerman I, Fransen M, Bridgett L, Williams S, Guillemin F. The global burden of hip and knee osteoarthritis: estimates from the Global Burden of Disease 2010 study. Annals of the Rheumatic Diseases. 2014;73(7):1323-1330. https://doi.org/10.1136/annrheumdis-2013-204763
Ivkin DYu, Ivkina AS. Symptoms of delayed action in the therapy of osteoarthritis. Lechaschii vrach. 2012;7:100-104. (In Russ.) https://www.lvrach.ru/2012/07/15435482/
Folomeeva OM, Erdes ShF. Prevalence and social significance of rheumatic diseases in the Russian Federation. Doktor (revmatologiya). 2007;10:3-12. (In Russ.)
WHO Scientific Group on the Burden of Musculoskeletal Conditions at the Start of the Millennium. The Burden of Musculoskeletal Disease at the Start of the Millennium: report of a WHO scientific group. Geneva: WHO; 2003. http://www.who.int/iris/handle/10665/42721
Roach HI, Aigner T, Soder S, Haag J, Welkerling H. Pathobiology of osteoarthritis: pathomechanisms and potential therapeutic targets. Current Drug Targets. 2007;8(2):271-282.
Partridge SM. The chemistry of connective tissues. The state of combination of chondroitin sulphate in cartilage. Biochemical Journal. 1948;43(3):387-397.
Alfred JB, John RH, Benjamin CS. Chondroitin sulfate concentration and protein-polysaccharide composition of articular cartilage in osteoarthritis. Journal of Clinical Investigation. 1963;42(6):853-859. https://doi.org/10.1172/JCI104777
Baici A, Bradamante P. Interaction between human leukocyte elastase and chondroitin sulfate. Chemico-Biological Interactions. 1984;51:1-11. https://doi.org/10.1016/0009-2797(84)90015-2
Monfort J, Nacher M, Montell E, Vila J, Verges J, Benito P. Chondroitin sulfate and Hyaluronic acid (500―730 kDa) inhibit stromelysin-1 synthesis in human osteoarthritic chondrocytes. Drugs under experimental and clinical research. 2005;31:71-76.
Chou MM, Vergnolle N, McDougall JJ, Wallace JL, Marty S, Teskey V, Buret AG. Effects of chondroitin and glucosamine sulfate in a dietary bar formulation on inflammation, interleukin-1beta, matrix metalloprotease-9, and cartilage damage in arthritis. Experimental Biology and Medicine. 2005;230:255-262.
Martel-Pelletier J, Roubille C, Abram F, Hochberg MC, Dorais M, Delorme P, Raynauld J-P, Pelletier J-P. First-line analysis of the effects of treatment on progression of structural changes in knee osteoarthritis over 24 months: data from the osteoarthritis initiative progression cohort. Annals of the Rheumatic Diseases. 2015;74(3):547-556. https://doi.org/10.1136/annrheumdis-2013-203906
Verbruggen G, Veys EM. Influence of sulphated glycosaminoglycans upon proteoglycan metabolism of the synovial lining cells. Acta Rhumatologica Belgica. 1977;1:75-92.
Lippielo L, Grande D. In vivo chondroprotection of glucosamine and chondroitin sulfate in a rabbit model of a OA and demonstration of metabolic synergy on chondrocyte in vitro. Annals of the Rheumatic Diseases. 2000;59(I):266.
Chan PS, Caron JP, Orth MW. Shot-term gene expression changes in cartilage explants stimulated with interleukin beta plus glucosamine and chondroitin sulfate. Journal of Rheumatology. 2006;33:1329-1340.
Conrozier Т. Death of articular chondrocytes. Mechanisms and protection. Presse Medicale. 1998;21:1859-1861.
Largo R, Sanches-Pernaute O, Moreno-Rubio J. Chondroitin sulfate prevents synovial inflammation in an experimental model of chronic arthritis, which might be mediated by the inhibition of the NF-kB dependent pathway. Osteoarthritis and Cartilage. 2008;16(4):28-29.
Ronca F, Palmieri L, Panicucci P, Ronca G. Anti-inflammatory activity of chondroitin sulfate. Osteoarthritis and Cartilage. 1998;6(A):14-21.
Ishiguro N, Thonar EJ, Uebelhart D, Williams JM. Immunolocalization of atypical chondroitin sulfate chains in rabbit articular cartilage after chymopapain-induced injury. Osteoarthritis and Cartilage. 1994;2(4):285-288.
Henrotin Y, Lambert С. Chondroitin and Glucosamine in the Management of Osteoarthritis: An Update. Current Rheumatology Reports. 2013;15:361. https://doi.org/10.1007/s11926-013-0361-z
Henrotin Y, Marty M, Mobasheri A. What is the current status of chondroitin sulfate and glucosamine for the treatment of knee osteoarthritis? Maturitas. 2014;78:184-187. https://doi.org/10.1016/j.maturitas.2014.04.015.
Blitterswijk WJ, van de Nes JCM, Wuisman PIJM. Glucosamine and chondroitin sulfate supplementation to treat symptomatic disc degeneration: Biochemical rationale and case report. BMC Complementary and Alternative Medicine. 2003;3(1):2. https://doi.org/10.1186/1472-6882-3-2
Zhang W, Doherty M, Arden N, Bannwarth B, Bijlsma J, Gunther KP, Hauselmann HJ, Herrero-Beaumont G. EULAR evidence based recommendations for the management of hiposteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Annals of the Rheumatic Diseases. 2005;64(5):669-681. https://doi.org/10.1136/ard.2004.028886
Singh JA, Noorbaloochi S, MacDonald R, Maxwell LJ. Chondroitin for osteoarthritis. Cochrane Database of Systematic Reviews. 2015;1. https://doi.org/10.1002/14651858.CD005614.pub2
Danilov AB. The antinociceptive effect of chondroprotectors is a myth or a reality? Manage pain. 2018;1:8-13. (In Russ.) http://logospress.ru/data/med/MP/2018/1-2018/Danilov-1_MP-1-2018.pdf
Instruktsiya po meditsinskomu primeneniyu preparata Mukosat. R №000570/01 ot 28.03.16. https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=a7bae10b-9e5d-4b38-9b29-0149fdeb8419&t=cd250c0e-1699-4b0a-a7ca-226f6c198a3d

Close metadata